China National Pharmaceutical Corporation
GPTKB entity
Statements (76)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:accessories |
logistics companies
international suppliers local distributors |
| gptkbp:acquired |
GSK's vaccines business in China
|
| gptkbp:acquisition |
various international pharmaceutical companies
|
| gptkbp:affiliation |
various global pharmaceutical associations
|
| gptkbp:awards |
various industry awards
|
| gptkbp:business_model |
vertical integration
|
| gptkbp:ceo |
Liang Zhiqiang
|
| gptkbp:clinical_trial |
Phase IV
Phase II collaborative projects Phase III Phase I numerous ongoing |
| gptkbp:collaborations |
academic institutions
|
| gptkbp:community_engagement |
healthcare initiatives
|
| gptkbp:customer_base |
hospitals and clinics
pharmacies government health programs |
| gptkbp:distributor |
multiple countries
|
| gptkbp:employees |
over 100,000
|
| gptkbp:export_markets |
raw materials
|
| gptkbp:exported_to |
pharmaceutical products
|
| gptkbp:financial_performance |
strong growth
|
| gptkbp:financial_reports |
annual reports
quarterly reports investor presentations |
| gptkbp:financials |
health insurance partnerships
|
| gptkbp:founded |
gptkb:1998
|
| gptkbp:has_culture |
innovation-driven
|
| gptkbp:headquarters |
gptkb:Beijing,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
China National Pharmaceutical Corporation
|
| gptkbp:industry |
gptkb:pharmaceuticals
|
| gptkbp:innovation |
focus on new drug development
|
| gptkbp:invention |
numerous pharmaceutical patents
|
| gptkbp:investment |
biotechnology research
|
| gptkbp:market |
competitive analysis
trend analysis consumer insights |
| gptkbp:market_cap |
approximately $20 billion
|
| gptkbp:market_position |
dominant in China
|
| gptkbp:marketing_strategy |
diversification
|
| gptkbp:operates_in |
gptkb:China
international markets |
| gptkbp:parent_company |
gptkb:China_National_Pharmaceutical_Group
|
| gptkbp:partnerships |
various global health organizations
with international NGOs with WHO with UNICEF |
| gptkbp:product |
collaborative efforts
|
| gptkbp:product_line |
generic drugs
prescription medications OTC medications |
| gptkbp:product_quality |
high standards
|
| gptkbp:production_location |
multiple locations in China
|
| gptkbp:products |
vaccines
biopharmaceuticals diagnostics |
| gptkbp:regulatory_compliance |
international standards
|
| gptkbp:research_and_development |
extensive
|
| gptkbp:research_focus |
rare diseases
chronic diseases infectious diseases |
| gptkbp:revenue |
over $30 billion
|
| gptkbp:social_responsibility |
healthcare access initiatives
|
| gptkbp:strategic_goals |
global expansion
|
| gptkbp:subsidiaries |
gptkb:Sinopharm_Group
|
| gptkbp:supply_chain |
global
efficient logistics |
| gptkbp:sustainability_initiatives |
environmental responsibility
|
| gptkbp:training |
continuous development
|
| gptkbp:website |
www.sinopharm.com
|
| gptkbp:bfsParent |
gptkb:China_National_Pharmaceutical_Group
|
| gptkbp:bfsLayer |
6
|